Challenges and recommendations for early identification of metastatic disease in prostate cancer Journal Article


Authors: Crawford, E. D.; Stone, N. N.; Yu, E. Y.; Koo, P. J.; Freedland, S. J.; Slovin, S. F.; Gomella, L. G.; Berger, E. R.; Keane, T. E.; Sieber, P.; Shore, N. D.; Petrylak, D. P.
Article Title: Challenges and recommendations for early identification of metastatic disease in prostate cancer
Abstract: Prostate cancer is often associated with metastases to bone and/or soft tissue. The progression to metastatic castrate-resistant prostate cancer is a seminal event in disease progression affecting treatment decisions. A multidisciplinary group was convened to review the currently available imaging guidelines for metastatic disease in prostate cancer and found no consensus on eligibility criteria, type of imaging modality, and the frequency of scanning for detecting metastatic disease. The aim of this review was to present the recommendations from the group to identify optimal strategies for early identification of metastases in patients with prostate cancer.
Keywords: disease course; cancer growth; patient selection; nuclear magnetic resonance imaging; clinical practice; medical decision making; metastasis; clinical assessment; practice guideline; prostate cancer; gleason score; cost effectiveness analysis; patient care; early diagnosis; predictive value; bone scintiscanning; workshop; human; priority journal; article
Journal Title: Urology
Volume: 83
Issue: 3
ISSN: 0090-4295
Publisher: Elsevier Science, Inc.  
Date Published: 2014-03-01
Start Page: 664
End Page: 669
Language: English
DOI: 10.1016/j.urology.2013.10.026
PROVIDER: scopus
PUBMED: 24411213
DOI/URL:
Notes: Export Date: 2 April 2014 -- CODEN: URGYA -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Susan Slovin
    254 Slovin